|
|
| ||||||
MEDIA CENTER Population Council Selects Louise Pedneault as Clinical Director, Microbicides, HIV and AIDS Program NEW YORK (14 April 2008) — The Population Council appointed Louise Pedneault, M.D., clinical director of microbicides for the organization’s HIV and AIDS program. In addition to managing clinical trials, Pedneault will work on strategic planning for next-generation microbicide candidates as part of the Council’s continued commitment to develop products that provide women with the means for protecting themselves from HIV infection.
A physician with a specialization in infectious diseases and medical microbiology, Pedneault brings to the Council a decade of experience in the clinical development of HIV and AIDS medications and vaccines through her work in the pharmaceutical industry (at Bristol-Myers Squibb Company, Glaxo Wellcome, and GlaxoSmithKline). She also worked in the academic setting as an assistant professor, Department of Microbiology and Immunology, University of Montreal. Pedneault received an M.Sc. in microbiology and immunology and an M.D. from the University of Montreal. She earned a second master’s degree in international administration at the University of Miami, where she participated in a medical mission to provide care to the Mayan population in Guatemala. She speaks English, French, and Spanish. In 2007, the Council completed a Phase 3 clinical trial of its candidate microbicide, Carraguard®, the first to reach this advanced phase of clinical research. Building on this work, the Council is developing next-generation microbicides with new formulations and mechanisms of action. Additional information about the Council’s microbicides program is available at www.popcouncil.org/microbicides.
|
